Stockscreener 앱 받기
1.67
2.34%
-0.04
시간 외 거래:
1.70
0.03
+1.80%
Engene Therapeutics Inc (ENGN) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Operating Expenses |
6.40%
34.01
|
31.97 | 31.18 | 39.48 | 29.95 |
| Operating Income/Loss |
6.40%
-34.01
|
-31.97 | -31.18 | -39.48 | -29.95 |
| Nonoperating Income/Loss |
13.10%
1.513
|
1.741 | 1.433 | 1.104 | 1.195 |
| Income/Loss From Continuing Operations Before Tax |
7.52%
-32.50
|
-30.23 | -29.75 | -38.38 | -28.75 |
| Income Tax Expense/Benefit |
-
|
- | - | -0.497 | 0.239 |
Net Income/Loss
|
7.52%
-32.50
|
-30.23 | -29.75 | -37.88 | -28.99 |
| Basic Average Shares |
0.01%
69.73
|
69.72 | 67.26 | 0.0879 | 51.10 |
| Diluted Average Shares |
0.01%
69.73
|
69.72 | 67.26 | 0.0879 | 51.10 |
| Basic Earnings Per Share |
9.30%
-0.47
|
-0.43 | 0.44 | 0.73 | 0.57 |
| Diluted Earnings Per Share |
9.30%
-0.47
|
-0.43 | 0.44 | 0.73 | 0.57 |
| Common Stock Dividends |
-
|
- | - | - | - |
4.22%
자본화:
|
볼륨(24시간):